[ad_1] David A. Owens (Vanderbilt University) David A. Owens, a leading thinker on innovation and new product development and Owen Graduate School of Management faculty member, has been named the Evans Family Executive Director of the Wond’ry. Owens is a professor of the practice of management and innovation and succeeds Robert Grajewski, the Wond’ry’s inaugural […]
Tag Archives: School of Medicine
Study details regulation of a multi-drug transporter | Vanderbilt News
[ad_1] Vanderbilt University researchers have discovered how a protein pump distinguishes between chemicals that it will expel from a cell and inhibitors that block its action. The pump, called P-glycoprotein, protects cells by removing potentially harmful chemicals, but it contributes to drug resistance when those chemicals are therapeutic drugs — which poses a particular problem […]
Frog fungus fights back | Vanderbilt News
[ad_1] Amphibian populations have been declining around the world for more than 40 years. One culprit is the fungus B. dendrobatidis, which causes the disease chytridiomycosis. Although amphibians have robust immune defenses, the response to this pathogen is often ineffective, suggesting that the fungus somehow counters the immune response. Louise Rollins-Smith, PhD, and colleagues previously discovered […]
Yohn named Postdoc of the Year at annual symposium; Sappington named Mentor of the Year | Vanderbilt News
[ad_1] By Irene McKirgan Samantha Yohn, 2019 Vanderbilt Postdoc of the Year. (Anne Rayner/Vanderbilt) Postdoctoral scholar Samantha Yohn has been named Postdoc of the Year by the Office of Postdoctoral Affairs for her exceptional research scholarship. Since 2008, the Postdoc of the Year award has recognized excellence in research scholarship as evidenced by publications, presentations, […]
Law School, VUMC team up on DHHS grant to develop and test “safe harbor” standards of care | Vanderbilt News
[ad_1] By Grace Renshaw (Getty) A team of researchers from Vanderbilt University’s schools of Law, Medicine and Management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test “safe harbor” standards of care based on scientific evidence. A goal […]
Researchers find high-risk genes for schizophrenia | Vanderbilt News
[ad_1] Using a unique computational framework they developed, a team of scientist cyber-sleuths in the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute (VGI) has identified 104 high-risk genes for schizophrenia. Their discovery, which was reported April 15 in the journal Nature Neuroscience, supports the view that schizophrenia is a […]
Asian nations in early tobacco epidemic: study | Vanderbilt News
[ad_1] Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases. That’s the conclusion of researchers from Vanderbilt-Ingram Cancer Center and the Vanderbilt Epidemiology Center after analyzing 20 prospective cohort […]
Team explores fungal infection quandary in lung cancer screenings | Vanderbilt News
[ad_1] Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs. Their work, published October 2018 in Emerging Infectious Diseases, revealed that histoplasmosis is prevalent beyond previously identified regions of the United States and led […]
Cancer’s SOS | Vanderbilt News
[ad_1] RAS proteins regulate growth, survival and proliferation of cells in their active state. However, the uncontrolled activation of RAS causes approximately a third of all tumors and helps cancerous cells evade anti-cancer drugs. Thus RAS is an important target for effective anti-cancer treatments. RAS proteins become “active” through the exchange of guanine nucleotides (GTP […]
Cardiac dysfunction in Duchenne’s | Vanderbilt News
[ad_1] Duchenne muscular dystrophy (DMD) is a severe muscle disease that causes progressive muscle weakening and degeneration. Cardiomyopathy is the leading cause of death in DMD, but standard markers of heart failure are poor indicators of disease. Determining factors involved in DMD cardiomyopathy could identify novel biomarkers to follow disease progression and as targets for […]